Zhejiang Dayang Biotech Group Co (SHE:003017) — Market Cap & Net Worth
Market Cap & Net Worth: Zhejiang Dayang Biotech Group Co (003017)
Zhejiang Dayang Biotech Group Co (SHE:003017) has a market capitalization of $327.45 Million (CN¥2.24 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #14519 globally and #4341 in its home market, demonstrating a -1.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Dayang Biotech Group Co's stock price CN¥22.20 by its total outstanding shares 100800000 (100.80 Million). Also see Zhejiang Dayang Biotech Group Co assets under control for a full breakdown of the balance sheet.
Zhejiang Dayang Biotech Group Co Market Cap History: 2020 to 2026
Zhejiang Dayang Biotech Group Co's market capitalization history from 2020 to 2026. Data shows change from $499.65 Million to $327.45 Million (-3.38% CAGR). Also see Zhejiang Dayang Biotech Group Co (003017) cash conversion ratio for how efficiently the company converts equity into cash flow.
Zhejiang Dayang Biotech Group Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Dayang Biotech Group Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Zhejiang Dayang Biotech Group Co (003017) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.42x
Zhejiang Dayang Biotech Group Co's market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.41x
Zhejiang Dayang Biotech Group Co's market cap is 4.41 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $499.65 Million | $678.34 Million | $91.61 Million | 0.74x | 5.45x |
| 2021 | $409.77 Million | $783.21 Million | $70.01 Million | 0.52x | 5.85x |
| 2022 | $276.82 Million | $1.06 Billion | $80.73 Million | 0.26x | 3.43x |
| 2023 | $348.26 Million | $919.45 Million | $50.01 Million | 0.38x | 6.96x |
| 2024 | $274.65 Million | $909.96 Million | $63.75 Million | 0.30x | 4.31x |
| 2025 | $440.44 Million | $1.05 Billion | $99.85 Million | 0.42x | 4.41x |
Competitor Companies of 003017 by Market Capitalization
Companies near Zhejiang Dayang Biotech Group Co in the global market cap rankings as of September 19, 2026. Review tangible equity quality of Zhejiang Dayang Biotech Group Co to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Zhejiang Dayang Biotech Group Co by market ranking:
- BASF SE (F:BASA): Ranked #598 globally with a market cap of $45.63 Billion USD ( €39.03 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #625 globally with a market cap of $44.13 Billion USD ( €37.75 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #1069 globally with a market cap of $25.31 Billion USD ( CN¥172.99 Billion CNY).
- Dow Inc (NYSE:DOW): Ranked #1248 globally with a market cap of $20.71 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #598 | BASF SE | F:BASA | $45.63 Billion | €12.70 |
| #625 | BASF SE | XETRA:BAS | $44.13 Billion | €51.62 |
| #1069 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $25.31 Billion | CN¥23.59 |
| #1248 | Dow Inc | NYSE:DOW | $20.71 Billion | $28.73 |
Zhejiang Dayang Biotech Group Co Historical Marketcap From 2020 to 2026
Between 2020 and today, Zhejiang Dayang Biotech Group Co's market cap moved from $499.65 Million to $ 327.45 Million, with a yearly change of -3.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥327.45 Million | -25.65% |
| 2025 | CN¥440.44 Million | +60.37% |
| 2024 | CN¥274.65 Million | -21.14% |
| 2023 | CN¥348.26 Million | +25.81% |
| 2022 | CN¥276.82 Million | -32.45% |
| 2021 | CN¥409.77 Million | -17.99% |
| 2020 | CN¥499.65 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Zhejiang Dayang Biotech Group Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $327.45 Million USD |
| MoneyControl | $327.45 Million USD |
| MarketWatch | $327.45 Million USD |
| marketcap.company | $327.45 Million USD |
| Reuters | $327.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang Dayang Biotech Group Co
Zhe Jiang Dayang Biotech Group Co., Ltd. operates as a chemical raw material manufacturing company in China and internationally. The company offers inorganic chemicals, including potassium bicarbonate, ammonium chloride, manufactures and sales bicarbonate food and feed additives; veterinary drugs; potassium bicarbonate; and ammonium chloride. It also provides 2-chloro-6-fluorobenzoic acid, fluoro… Read more